MedTrace Logo

Epigenetics Based Diagnosis of Diabetes in Saliva and Blood Samples

NCT04011228 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 224

Last updated 2019-09-03

No results posted yet for this study

Summary

The aim of the present study is to investigate epigenetics based modifications and biomarkers in the saliva and blood in diabetic patients.

Conditions

  • Prediabetic State
  • Diabetes Mellitus, Type 2
  • Ectopic Lipids
  • Epigenetics Based Modifications

Interventions

DIAGNOSTIC_TEST

Blood sampling

After a fasting period over night blood samples will be taken.

DIAGNOSTIC_TEST

Saliva and blood samples

After a fasting period over night blood and saliva samples will be taken for the investigation of epigenetics based modifications.

DIAGNOSTIC_TEST

Magnet Resonance Spectroscopy

The amount of ectopic lipids in the liver, heart and the skeletal muscle will be measured using 1H-magnetic resonance spectroscopy.

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Alexandra Kautzky-Willer, Univ.Prof.Dr. · Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Unit of Gender Medicine, Medical University of Vienna

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2019-12-11
Completion
2020-01-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04011228 on ClinicalTrials.gov